Molecular dynamics simulations and novel drug discovery

Area of Science:

• Computational Biology
• Biophysics
• Drug Discovery

Background:

• Molecular dynamics (MD) simulations provide extensive dynamical structural and energetic data on biomacromolecules and their interactions.
• This information is critical for understanding structure-function relationships and guiding drug discovery and design.
• MD simulations are widely and successfully employed across all stages of modern drug discovery.

Purpose of the Study:

• To review the diverse applications of MD simulations in novel drug discovery.
• To highlight the role of MD in understanding pathogenic mechanisms of diseases like amyloidosis.
• To discuss the utility of MD in virtual screening and elucidating drug-target interaction mechanisms.

Main Methods:

• Review of existing literature on MD simulation applications in drug discovery.
• Analysis of MD's role in studying protein misfolding diseases and amyloidosis.
• Examination of MD's contribution to virtual screening and drug resistance mechanism investigations.

Main Results:

• MD simulations are instrumental in investigating disease mechanisms caused by protein misfolding.
• MD simulations are effectively used in virtual screening processes.
• MD simulations aid in understanding drug resistance mechanisms driven by target mutations.

Conclusions:

• MD simulations offer solutions to complex problems in disease research and drug development that are challenging for experimental methods alone.
• Future advancements in computational power, sampling techniques, force fields, and analysis methods will expand the applications of MD simulations.
• MD simulations are poised to become even more integral to drug discovery and understanding complex biological systems.